Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy

American Journal of Ophthalmology

Volumn 151, Issue 4, 2011, Pages 594-603.e1

  Maruko, Ichiro ^a   Iida, Tomohiro ^a   Sugano, Yukinori ^a   Saito, Masaaki ^a   Sekiryu, Tetsuju ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VERTEPORFIN;

ADULT; AGED; ARTICLE; CHOROID THICKNESS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA THICKNESS; TREATMENT OUTCOME; VISUAL SYSTEM PARAMETERS;

EID: 79952992628     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.10.030     Document Type: Article

References (47)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trialsTAP Report 1 Arch Ophthalmol 117 10 1999 1329 1345
2. Japanese Age-Related Macular Degeneration Trial (JAT) Study Group Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 6 2003 1049 1061
3. Verteporfin Roundtable 2000 and 2001 Participants; Study Group Principal Investigators Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes Retina 22 1 2002 6 18
4. Verteporfin Roundtable Participants Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update Retina 25 2 2005 119 134
5. Y. Tano Ophthalmic PDT Study Group Guidelines for PDT in Japan Ophthalmology 115 3 2008 585 585.e6
6. M. Quaranta, M. Mauget-Fasse, and G. Coscas Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Am J Ophthalmol 134 2 2002 277 280 (Pubitemid 34831840)
7. R.F. Spaide, I. Donsoff, and D.L. Lam Treatment of polypoidal choroidal vasculopathy with photodynamic therapy Retina 22 5 2002 529 535 (Pubitemid 35176066)
8. W.M. Chan, D.S. Lam, and T.Y. Lai Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 8 2004 1576 1584 (Pubitemid 39030815)
9. A. Otani, M. Sasahara, and Y. Yodoi Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 144 1 2007 7 14
10. E. Akaza, R. Mori, and M. Yuzawa Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy Retina 28 5 2008 717 722 (Pubitemid 351655124)
11. M. Saito, T. Iida, and D. Nagayama Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment Br J Ophthalmol 92 12 2008 1642 1647
12. U. Schmidt-Erfurth, T. Hasan, and E. Gragoudas Vascular targeting in photodynamic occlusion of subretinal vessels Ophthalmology 101 12 1994 1953 1961
13. M. Kramer, J.W. Miller, and N. Michaud Liposomal benzoporphyrin derivative verteporfin photodynamic therapy Selective treatment of choroidal neovascularization in monkeys Ophthalmology 103 3 1996 427 438 (Pubitemid 26085897)
14. U. Schmidt-Erfurth, H. Laqua, and U. Schltzer-Schrehard Histopathological changes following photodynamic therapy in human eyes Arch Ophthalmol 120 6 2002 835 844 (Pubitemid 34620368)
15. U. Schltzer-Schrehardt, A. Viestenz, and G.O. Naumann Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes Graefes Arch Clin Exp Ophthalmol 240 9 2002 748 757 (Pubitemid 36104156)
16. U. Schmidt-Erfurth, S. Michels, I. Barbazetto, and H. Laqua Photodynamic effects on choroidal neovascularization and physiological choroid Invest Ophthalmol Vis Sci 43 3 2002 830 841 (Pubitemid 34184504)
17. A.H. Rogers, A. Martidis, P.B. Greenberg, and C.A. Puliafito Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization Am J Ophthalmol 134 4 2002 566 576 (Pubitemid 35304647)
18. R.A. Costa, M.E. Farah, and J.A. Cardillo Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization Retina 23 2 2003 159 165 (Pubitemid 36548806)
19. U. Schmidt-Erfurth, U. Schltzer-Schrehard, and C. Cursiefen Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor Invest Ophthalmol Vis Sci 44 10 2003 4473 4480 (Pubitemid 37186285)
20. Y. Hirami, A. Tsujikawa, and A. Otani Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy Retina 27 3 2007 335 341 (Pubitemid 46398898)
21. K. Ishikawa, M. Kondo, and Y. Ito Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy Invest Ophthalmol Vis Sci 48 5 2007 2254 2259 (Pubitemid 351261303)
22. H. Koizumi, T. Iida, and D. Nagayama Indocyanine green angiography in eyes with substantially increased subretinal fluid 1 week after photodynamic therapy Retinal Cases & Brief reports 2 1 2008 12 14
23. V. Isola, A. Pece, and M.B. Parodi Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization Am J Ophthalmol 142 4 2006 885 887 (Pubitemid 44584139)
24. R. Mukai, S. Kishi, and T. Sato Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapy Ophthalmologica 224 5 2010 267 273
25. D.S. Boyer, A.N. Antoszyk, C.C. Awh MARINA Study Group Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2 2007 246 252 (Pubitemid 46172497)
26. P.K. Kaiser, D.M. Brown, and K. Zhang Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results Am J Ophthalmol 144 6 2007 850 857
27. P.K. Kaiser, B.A. Blodi, H. Shapiro, N.R. Acharya MARINA Study Group Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 10 2007 1868 1875
28. F. Gomi, M. Sawa, and H. Sakaguchi Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 1 2008 70 73
29. T.Y. Lai, W.M. Chan, and D.T. Liu Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy Br J Ophthalmol 92 5 2008 661 666 (Pubitemid 351684177)
30. G.T. Kokame, L. Yeung, and J.C. Lai Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: an Interim 6-month report Br J Ophthalmol 94 3 2010 297 301
31. A.N. Antoszyk, L. Tuomi, C.Y. Chung, A. Singh FOCUS Study Group Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results Am J Ophthalmol 145 5 2008 862 874
32. M. Saito, C. Shiragami, and F. Shiraga Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation Am J Ophthalmol 146 6 2008 935 941 e1
33. C.G. Kiss, C. Simader, S. Michels, and U. Schmidt-Erfurth Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the protect study Br J Ophthalmol 92 12 2008 1620 1627
34. P.K. Kaiser Registry of Visudyne AMD Therapy Writing Committee Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration Ophthalmology 116 4 2009 747 755 755.e1
35. R.F. Spaide, H. Koizumi, and M.C. Pozonni Enhanced depth imaging spectral-domain optical coherence tomography Am J Ophthalmol 146 4 2008 496 500
36. T. Wygnanski-Jaffe, H. Desatnik, and A. Alhalel ICG angiography-guided photodynamic therapy for large pigment epithelial detachments in age-related macular degeneration Ophthalmic Surg Lasers Imaging 37 5 2006 358 363 (Pubitemid 44519239)
37. A. Otani, M. Sasahara, and Y. Yodoi Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 144 1 2007 7 14
38. C.M. Eandi, M.D. Ober, and K.B. Freund Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization Retina 27 7 2007 825 831 (Pubitemid 47479375)
39. L.A. Yannuzzi, D.W. Wong, and B.S. Sforzolini Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration Arch Ophthalmol 117 11 1999 1503 1510 (Pubitemid 29536478)
40. K. Sho, K. Takahashi, and H. Yamada Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 10 2003 1392 1396 (Pubitemid 37243739)
41. I. Maruko, T. Iida, and M. Saito Clinical characteristics of exudative age-related macular degeneration in Japanese patients Am J Ophthalmol 144 1 2007 15 22
42. W.E. Smiddy Economic implications of current age-related macular degeneration treatments Ophthalmology 116 3 2009 481 487
43. L.J. Hernandez-Pastor, A. Ortega, A. Garcia-Layana, and J. Giraldez Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration Clin Ther 30 12 2008 2436 2451
44. M. Sasahara, A. Tsujikawa, and K. Musashi Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability Am J Ophthalmol 142 4 2006 601 607
45. Y. Imamura, F. Fujiwara, R. Margolis, and R.F. Spaide Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy Retina 29 10 2009 1469 1473
46. S. Ozawa, K. Ishikawa, and Y. Ito Differences in macular morphology between polypoidal choroidal vasculopathy and exudative age-related macular degeneration detected by optical coherence tomography Retina 29 6 2009 793 802
47. I. Maruko, T. Iida, and Y. Sugano Subfoveal choroidal thickness after treatment of central serous chorioretinopathy Ophthalmology 117 9 2010 1792 1799